![](/img/cover-not-exists.png)
Phase II Evaluation of Oral Estramustine, Oral Etoposide, and Intravenous Paclitaxel in Patients with Hormone-Sensitive Prostate Adenocarcinoma
Niklas J. Mackler, Kenneth J. Pienta, Rodney L. Dunn, Kathleen A. Cooney, Bruce G. Redman, Karin B. Olson, Judith E. Fardig, David C. SmithVolume:
5
Year:
2007
Language:
english
DOI:
10.3816/cgc.2007.n.010
File:
PDF, 127 KB
english, 2007